Global Biodefense Market 2020-2024

Home > Market Research Reports > Defense & Aerospace

	Market Research Report Global Biodefense Market 2020-2024
Published by	TechNavio (Infiniti Research Ltd.)			Product code	938108
Published	May 15, 2020	Content info	120 Pages Delivery time: 1-2 business days
Price	PDF by E-mail (Single User License) USD 2500 PDF by E-mail (5-user License) USD 3000 PDF by E-mail (Enterprise License) USD 4000 PDF by E-mail (Global License) USD 5000

Description

Technavio has been monitoring the biodefense market and it is poised to grow by $ 3.22 billion during 2020-2024 progressing at a CAGR of 8% during the forecast period. Our reports on biodefense market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing threat of bioterrorism, rapid increase in government funding in R&D and recent outbreaks of infectious diseases. In addition, growing threat of bioterrorism is anticipated to boost the growth of the market as well.

The biodefense market analysis includes application segment and geographic landscapes

Technavio's ‘biodefense market ’ is segmented as below:

By Application:

Anthrax
Smallpox
Botulism
Others

By Geographic Landscape:

North America
Europe
Asia
ROW

This study identifies the government initiatives as one of the prime reasons driving the biodefense market growth during the next few years. Also, growing collaborations and M&A and increasing healthcare expenditure will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our biodefense market covers the following areas:

Biodefense market sizing
Biodefense market forecast
Biodefense market industry analysis"

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biodefense market vendors that include Alexeter Technologies LLC, Alnylam Pharmaceuticals Inc., Altimmune Inc., ANP Technologies Inc., Bavarian Nordic AS, Cleveland BioLabs Inc., Elusys Therapeutics Inc., Emergent BioSolutions Inc., General Dynamics Corp., and GlaxoSmithKline Plc. Also, the biodefense market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.